Award
National Cancer Institute 11047109
Mechanistic dissection and inhibitor targeting of autophagy in RAS driven cancers
Recipient
National Cancer Institute (NCI)
Award Amount
$717,245.00
Ceiling
$717,245.00
Awarded
July 14, 2025
Identifier
11047109
Research project funded by the National Cancer Institute to study autophagy in RAS-driven cancers and evaluate autophagy inhibitors for potential clinical use.
Description
The project involves studies on autophagy in RAS-driven cancers, with a focus on pancreatic ductal adenocarcinoma (PDAC). The research aims to evaluate autophagy inhibitors and mechanisms of resistance, with potential clinical applications. Funding is provided by the National Cancer Institute under grant PAR-21-138.